-
, performing data collection and processing of cryo-EM data. Setup of future hardware and software as the research technology is upgraded. Providing lab members support in data collection, image processing, map
-
used clinically to make small lesions in the brain circuitry responsible for both ET and PD, additional work has shown that when applied at lower intensity and frequency, it can be used to transiently
-
the cellular crosstalk and basic molecular mechanisms during lung repair and disease. We utilize in vivo mouse genetics, live imaging, 3D organoids, functional screening, and next-generation sequencing
-
, wearable devices, neuroimaging, and –omi cs data from electronic health record, registry, and research initiative s; and (2) develop and apply novelstatistical models to investigate gen e by environment
-
physiology, behavioral analysis, genetic models, chemistry and toxicology to examine the effects of flavor additives in electronic cigarettes and other tobacco products on nicotine use initiation and health
-
key regulators of inflammation and tissue remodeling in gut and skin diseases. • Apply and refine AI/ML methods, including deep learning, neural networks, and interpretable models (e.g., SHAP, BioMapAI
-
variety of scientific disciplines. Our mission is to produce integrated multi-omics and physiologic profiles of chronic human diseases, and to use such profiles to develop new disease detection strategies
-
on applying cutting-edge neuroscience techniques toward studying the nervous system of the heart. Qualifications: Education 5 years or less from a PhD or MD/PhD Degree with a background in cardiac biology
-
surrounding targeted therapeutic development. Current project teams employ synaptic physiology, in vivo chemicogenetic circuit manipulations, behavioral phenotyping, 2PLSM calcium imaging of direct and indirect